
Mighop 40mg Tablet SR
Marketer
Anax Lifescience
Salt Composition
Propranolol (40mg)
Overview Mighop 40mg Tablet SR
Anxiolytic and tremor-reducing properties are offered by the extended-release Mighop 40mg tablet. It's also indicated for migraine prophylaxis, angina pectoris management, and gastrointestinal bleeding stemming from portal hypertension. Furthermore, Mighop 40mg Tablet SR may treat hypertension and certain arrhythmias. Dosage is individualized, determined by your condition and response. Strict adherence to your physician's prescription is crucial. Administer on an empty stomach, consistently at the same time daily. Continued use, even feeling well, is vital for sustained benefit; abrupt cessation can exacerbate your condition. Frequent side effects include fatigue, weakness, Raynaud's phenomenon, bradycardia or arrhythmia, paresthesia, and dyspnea. Nausea, vomiting, and diarrhea may also occur. Report persistent or troublesome side effects to your doctor. Most adverse reactions are transient, resolving with continued treatment. Contraindicated in patients with asthma, significant bradycardia or arrhythmias, or severe cardiac conditions such as heart failure. Consult your physician before use if you have renal or hepatic impairment or COPD. Alcohol consumption can interfere with its efficacy and should be avoided. Refrain from driving if dizziness occurs. Pregnant or breastfeeding individuals should seek medical advice regarding its suitability.
Primary Ingredients of Mighop 40mg Tablet SR
No text provided to rephrase.
Uses of Mighop 40mg Tablet SR
Managing angina pectoris (chest pain linked to heart disease)|Correcting cardiac arrhythmias|Reducing the risk of myocardial infarction|Controlling hypertension (high blood pressure)|Addressing anxiety disorders|Alleviating tremors|Preventing migraine episodes|Treating pheochromocytoma
Major Benefits of Mighop 40mg Tablet SR:
Administer this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Mighop 40mg Tablet SR should be taken on an empty stomach. Refrain from consuming Mighop 40mg Tablet SR with meals high in fat, including items like olive oil, nuts and seeds (including Brazil nuts), dark chocolate, butter, and meat products.
Common Side effects of Mighop 40mg Tablet SR:
- Cold extremities
- Sleep disturbance
- Fatigue
- Slow heart rate
- Nightmares
How to use Mighop 40mg Tablet SR:
Administer Mighop 40mg Tablet SR precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. This medication should be taken on an empty stomach. Refrain from consuming Mighop 40mg Tablet SR with meals high in fat, including but not limited to olive oil, nuts and seeds (like Brazil nuts), dark chocolate, butter, and red meat.
How Mighop 40mg Tablet SR works:
Mighop 40mg SR tablets utilize propranolol, a beta-adrenergic blocking agent, to modulate the body's physiological response to nerve signals, particularly within the cardiovascular system. This medication reduces heart rate and improves the heart's pumping efficiency, thus mitigating arrhythmias. Simultaneously, it promotes vasodilation, enhancing circulation and offering relief from angina and migraine headaches. The precise mechanism by which it reduces tremors remains unclear, though it's hypothesized that Mighop 40mg SR inhibits nerve impulses to the affected muscles. Propranolol counteracts the effects of adrenaline and noradrenaline, neurotransmitters that elevate heart rate and contribute to anxiety; this action provides anxiolytic benefits. In pheochromocytoma management, Mighop 40mg SR can counteract excessive adrenaline hormone activity, reducing the risk of dangerously elevated blood pressure during tumor resection.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol consumption and Mighop 40mg Tablet SR is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Extended-release Mighop 40mg tablets may pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescription. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
Prolonged-release Mighop 40mg tablets are likely not safe for breastfeeding mothers. Available human data indicate potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyCAUTION
For individuals with severe kidney impairment, the use of Mighop 40mg Tablet SR necessitates careful monitoring. Dosage modification of Mighop 40mg Tablet SR might be necessary. Physician consultation is advised.
LiverCAUTION
Patients with liver impairment should use Mighop 40mg sustained-release tablets cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Mighop 40mg Tablet SR :
Should you forget a Mighop 40mg Tablet SR dose, take it immediately if feasible. Otherwise, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Mighop 40mg Tablet SR
| Label | Value |
|---|---|
| Pharmaceutical Category | Compounds derived from naphthalene |
| Potential for Dependence | None. |
| Type of Medication | HEART |
